| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Skye Bioscience, Inc. (SKYE) has 11 insiders with recent SEC Form 4 filings, including 1 buy and 0 sells. SKYE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.46M | $1.03M | - | |
| CEO | 280.0K | $198.5K | - | |
| Other | 150.0K | $106.3K | - | |
| Other | 125.0K | $88.6K | - | |
| Other | 125.0K | $88.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 29, 2023 | Dhillon Punit | Chief Executive Officer | Buy | 881,000 | $0.02 | $16,474.70 | +2.2% |